Exxel Pharma Inc. (EXXL)

Exxel Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Net Income	-1.27	-0.41	-0.43
Depreciation & Amortization	0.22	0.03	-
Share-Based Compensation	-	0.06	0
Other Operating Activities	0.29	-0.04	0.03
Operating Cash Flow	-0.77	-0.36	-0.4
Share Issuance / Repurchase	-	0.07	-
Debt Issued / Paid	-	0.51	-
Financing Cash Flow	1.12	0.57	-
Net Cash Flow	0.28	0.21	-0.41
Free Cash Flow	-0.77	-0.36	-0.4
Free Cash Flow Margin	-341.73%	-160.23%	-399.76%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).